Skip to content
Screener

Novanta NOVT Other Countries — Deferred Income Tax Expense Benefit

Similar metrics at other companies

Roivant Sciences logo
ROIVOther — Deferred Income Tax Expense Benefit
$0
Lesaka Technologies, Inc. logo
LSAKOther Income Tax — Deferred Income Tax Expense Benefit
-$4.5K-550%
Lesaka Technologies, Inc. logo
LSAKUS — Deferred Income Tax Expense Benefit
-$2.53M
Lesaka Technologies, Inc. logo
LSAKZA — Deferred Income Tax Expense Benefit
-$3.45M-409%
Wave Life Sciences logo
WVESG — Deferred Income Tax Expense Benefit
$0
Ovintiv logo
OVVCA — Deferred Income Tax Expense Benefit
$100M+3,233%

Other financials

Income statement

See full
Revenue$265.8M+10.3%
Gross profit$120.9M+13.3%
Operating income$18.1M+21.1%
Net income$12.5M+179%
EPS (diluted)$0.30+150%

Balance sheet

See full
Cash & equivalents$718.7M+554%
Total debt$285.6M-44.5%
Total equity$1.6B+102%
Total assets$2.1B+41.6%

Cash flow

See full
Operating cash flow$64.9M+331%
CapEx$7.5M+120%
Free cash flow$57.5M+392%

Valuation

See full
Market cap$5.82B+42.2%
Enterprise value$5.38B+19.7%
P/E94.2×+27.5×
P/S5.7×+1.4×

Profitability

See full
Gross margin44.5%-0.2pp
Operating margin9%-2.2pp
Net margin6%-0.4pp
FCF margin11.1%-1.2pp

Returns & leverage

See full
Return on equity5.1%-3.1pp
Debt / equity0.2×-0.5×
Current ratio4.6×+2.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The source filing: Novanta’s 10-K, filed February 23, 2026.

Filed
Feb 23, 2026, 4:57 PM EST
Fiscal year
FY2025
Accession
0001193125-26-064230
Line itemYear Ended December 31, 2025Year Ended December 31, 2024Year Ended December 31, 2023
Other22,92219,64711,113
24,66630,88825,596
Deferred
Canada
U.S.(5,124)(12,612)(12,224)
Other(3,729)(3,297)(2,502)
(8,853)(15,909)(14,726)
Total$15,813$14,979$10,870

Item 8. Financial Statements and Supplementary Data

FAQ

What is Novanta's other countries — deferred income tax expense benefit?
Novanta (NOVT) reported other countries — deferred income tax expense benefit of -$932.25K in Q4 2025.
How has Novanta's other countries — deferred income tax expense benefit changed year-over-year?
Novanta's other countries — deferred income tax expense benefit decreased by 13.1% year-over-year, from -$824.25K to -$932.25K.
What is the long-term trend for Novanta's other countries — deferred income tax expense benefit?
Over 4 years (2021 to 2025), Novanta's other countries — deferred income tax expense benefit has grown at a 12.8% compound annual growth rate (CAGR), from -$2.31M to -$3.73M.
What does other countries — deferred income tax expense benefit mean?
This metric captures the change in deferred tax assets and liabilities resulting from temporary differences between the financial reporting and tax reporting of a specific geographic segment. It indicates future tax consequences of events that have already been recognized in the financial statements. Investors analyze this to understand the timing differences in tax payments and potential future cash flow impacts.

Ask your AI about Novanta's other countries — deferred income tax expense benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude